118 results
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
29 May 24
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study
5:00pm
of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
23 May 24
Regulation FD Disclosure
5:20pm
of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
20 May 24
Regulation FD Disclosure
5:00pm
of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
8 May 24
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
4:30pm
of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
18 Apr 24
Results of Operations and Financial Condition
4:30pm
within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation
8-K
EX-99.1
z9q5t5 l4
12 Apr 24
Regulation FD Disclosure
8:30am
424B3
yoowtquto4461
28 Mar 24
Prospectus supplement
9:00am
424B3
pg1hrg69g1lsm97j
18 Mar 24
Prospectus supplement
1:09pm
8-K
EX-99.2
oqcsln ut2
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-10.1
0mr49wgq6z
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-99.1
b7u9gp5cvlalkm
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-99.1
b3k6pncm ak
29 Feb 24
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
5:00pm
8-K
EX-99.1
5h46fe0s1 ds760sblih
20 Feb 24
Other Events
5:05pm
8-K
EX-99.1
0n60u42i
9 Feb 24
Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
5:05pm
8-K
EX-99.1
ep0tf
7 Feb 24
Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds
5:05pm
8-K
EX-99.1
cpd963
2 Feb 24
Results of Operations and Financial Condition
5:15pm
8-K
EX-99.1
mi18m1d ow
30 Jan 24
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
rv9cammzp4luo7e44
26 Jan 24
Intelligent Bio Solutions Inc. Announces Reverse Stock Split
5:05pm